Abstract
An orphan disease is defined as a condition that affects fewer than 200,000 people nationwide and an orphan Drug is used to treat such a condition. However, these cases receive very little attention in developing nations such as India as compared to developed countries such as the United States, Europe, Japan and Australia. The purpose of this paper is to identify the hurdles in the field of orphan drugs in India and suggest solutions to address the same.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Paper Title
Journal
Date
